Akebia Therapeutics Inc. (AKBA)
NASDAQ · Healthcare
Akebia Therapeutics Inc. Shareholder Equity 2014–2025
Akebia Therapeutics Inc. annual shareholder equity history from 2014 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Akebia Therapeutics Inc. shareholder equity as of December 31, 2025: 32.6M, a 166.30% decrease year-over-year.
- Akebia Therapeutics Inc. shareholder equity for 2025 were 32.6M, a 166.30% decrease from 2024.
- Akebia Therapeutics Inc. shareholder equity for 2024 were -49.2M, a 60.82% increase from 2023.
- Akebia Therapeutics Inc. shareholder equity for 2023 were -30.6M, a 684.78% decrease from 2022.
- Akebia Therapeutics Inc. shareholder equity for 2022 were 5.2M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Akebia Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $33 |
| 2024 | $-49 |
| 2023 | $-31 |
| 2022 | $5 |
| 2021 | $74 |
| 2020 | $244 |
| 2019 | $393 |
| 2018 | $636 |
| 2017 | $123 |
| 2016 | $68 |
| 2015 | $131 |
| 2014 | $104 |
Akebia Therapeutics Inc. Shareholder Equity — FAQ
Akebia Therapeutics Inc. (AKBA) shareholder equity over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AKBA's shareholder equity history?
The chart and table above show Akebia Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.